Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Industry stakeholders have worked to enhance patient centricity in R&D in recent years in hopes of improving patient engagement and ensuring they have a stronger voice in their clinical care. This noticeable shift toward patient centricity also intends to help sponsors address long-standing challenges in successfully designing and executing clinical trials.
Decentralized Clinical Trials (DCT) solutions are being validated by accommodating patients' needs to improve their trial experiences and not compromise their safety and data quality, while at the same time benefiting sponsors by reducing trial delays and related costs (1).
Taking a closer look at connected devices and wearable technologies, including smart phones and watches, biosensors, and varying monitors (e.g., blood pressure, electrocardiogram, diabetes, etc.), finds that these specific DCT solutions are increasing in availability and use within trials.
Currently, there are nearly 670 studies either in recruitment or active stages incorporating wearables to examine these devices for use in various therapeutic areas, patient populations, and capacities (2). These devices collect an extensive breadth of data which allows sponsors and study teams to dive deeper into patient behavioral trends and capture richer insights near real-time that inform smarter decisions.
This article was part of International Clinical Trials February 2023 edition: https://www.calameo.com/read/006113385cea01a9a4adc?page=30
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Ensure you have access to insights early with connected devices and clean, analysis-ready data